| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 06/21/2007 | US20070140972 Targeting compositions and preparation therof |
| 06/21/2007 | US20070140971 contacting an ocular test sample with an N-phenolate betaine dye, wherein the dye undergoes a visible color change in less than about 30 minutes in the presence of bacteria at a pathogenic concentration, and thereafter detecting bacterial conjunctivitis based on the color change |
| 06/21/2007 | US20070140970 Cell targeting conjugates |
| 06/21/2007 | US20070140969 Method for comparing botulinum neurotoxins |
| 06/21/2007 | US20070140968 Method for determining botulinum potency |
| 06/21/2007 | US20070140962 Light Sensitive Compounds for Instant Determination of Organ Function |
| 06/21/2007 | US20070140960 Methods for imaging soluble a-beta |
| 06/21/2007 | DE20221699U1 Mehrfunktionelles, bioverträgliches Hydrogel More functional, biocompatible hydrogel |
| 06/21/2007 | DE102005058979A1 Magnetische Polymerpartikel Magnetic polymer particles |
| 06/20/2007 | EP1798219A1 Contrast agents |
| 06/20/2007 | EP1797903A1 Diagnostic agent for tumor |
| 06/20/2007 | EP1797114A2 Cupredoxin derived transport agents and methods of use thereof |
| 06/20/2007 | EP1797102A1 Composition comprising triarylmethyl radical, useful in mri diagnostics |
| 06/20/2007 | EP1796738A2 Diagnostic compounds for targeting a chemokine receptor |
| 06/20/2007 | EP1796736A2 Metalloproteinase inhibitor imaging agents |
| 06/20/2007 | EP1796734A1 Contrast agent formulations for the visualization of the lymphatic system |
| 06/20/2007 | EP1796733A2 Urokinase plasminogen activator receptor targeted contrast agents |
| 06/20/2007 | EP1796537A2 Dendrimer based compositions and methods of using the same |
| 06/20/2007 | EP1684723A4 Contrast medium comprising liposomes containing hydrophobic chelate compound |
| 06/20/2007 | EP1355913B1 Paramagnetic metal-phthalocyanine complex compounds and contrast agent using the same |
| 06/20/2007 | EP1281083B1 Methods for detecting inflammation and inflammatory conditions |
| 06/20/2007 | EP0605477B2 Gaseous ultrasound contrast media |
| 06/20/2007 | CN1321697C Ultrasound contrast medium composition with phospholipid as membrane material and its preparation method |
| 06/19/2007 | US7232796 Polypeptide for use as a medicament for treating bone defects, bone diseases and for improving bone regeneration |
| 06/19/2007 | US7232689 Adding a calibrant to an extraction phase prior to contact of extraction phase with sample, making contact between extraction phase and said sample for a predetermined extraction time, terminating contact and determining concentration of component using amounts of calibrant lost from extraction phase |
| 06/19/2007 | US7232657 Detection of drug-resistant human immunodeficiency virus |
| 06/19/2007 | US7232559 Diagnostic agents for pancreatic exocrine function |
| 06/19/2007 | CA2257304C Perlecan transgenic animals and methods of identifying compounds for the treatment of amyloidoses |
| 06/19/2007 | CA2073124C Tumor antigen specific antibody |
| 06/19/2007 | CA2013582C Method for enhancing transmembrane transport of exogenous molecules |
| 06/14/2007 | WO2007066247A2 System and method for monitoring in vivo drug release using overhauser-enhanced nmr |
| 06/14/2007 | WO2007065935A1 Aqueous dispersions of superparamagnetic single domain particles production and use thereof for diagnosis and therapy |
| 06/14/2007 | WO2007065265A1 Cross-linking reagents for hemoglobin and hemoglobin products cross-linked therewith |
| 06/14/2007 | WO2007027584A9 Deposit contrast agents and related methods thereof |
| 06/14/2007 | WO2007012962A3 Sono-active liposomes and lipid particles and use thereof as contrast agents and active-agent delivery systems |
| 06/14/2007 | WO2006065377A3 Methods of treating lentivirus infection |
| 06/14/2007 | WO2004043335A3 Methods of treating infection by drug resistant bacteria |
| 06/14/2007 | US20070136828 Methods of using molecules related to organic cation transporter 3 (oct3) for treating depression, anxiety neuroses, drug dependencies, and other similar mental disorders |
| 06/14/2007 | US20070135433 Imidazole derivatives as raf kinase inhibitors |
| 06/14/2007 | US20070134731 Proteomics based method for toxicology testing |
| 06/14/2007 | US20070134163 Radiographic contrasting agents and radio-opaque polymeric materials for medical devices |
| 06/14/2007 | US20070134162 Labeling reactant |
| 06/14/2007 | US20070134161 Methods of determining beta-iii tubulin expression |
| 06/14/2007 | US20070134160 Reagent system and method for modifying the luminescence of lanthanide(III) macrocyclic complexes |
| 06/14/2007 | US20070134159 Quantitation of sample properties using contrast enhancement from saturation transfer |
| 06/14/2007 | US20070134158 Method for comparing multiple botulinum neurotoxins |
| 06/14/2007 | US20070134157 Biological assay |
| 06/14/2007 | US20070134156 Fatigue evaluation apparatus, fatigue evaluation method, and application thereof |
| 06/14/2007 | US20070134155 useful in the treatment of heart failure, cardiac arrhythmias and other diseases where fibrosis is prominent such as in COPD, liver fibrosis, and atherosclerosis comprising a targeting moiety that demonstrates a higher binding affinity to the AT1 receptor than the native octapeptide Ang II |
| 06/14/2007 | US20070134153 Lipid-based drug delivery systems against parasitic infections |
| 06/14/2007 | DE102005059751A1 Wässrige Dispersion von superparamagnetischen Eindomänenteilchen, deren Herstellung und Verwendung zur Diagnose und Therapie Aqueous dispersion of superparamagnetic single-domain particles, their preparation and use for the diagnosis and therapy |
| 06/14/2007 | DE102005059242A1 Molekulare Marker für eine Tumordiagnose und -therapie Molecular markers for tumor diagnosis and therapy |
| 06/14/2007 | CA2826960A1 Targeting vector-phospholipid conjugates |
| 06/14/2007 | CA2630790A1 Optical determination of glucose utilizing boronic acid adducts-ii |
| 06/13/2007 | EP1795604A1 Telomelysin-gfp gene-containing recombinant virus |
| 06/13/2007 | EP1795209A2 Organic radiographic contrasting agents for medical devices |
| 06/13/2007 | EP1795208A1 Glycerophosphoric acid ester derivative having polyfunctional metal chelate structure |
| 06/13/2007 | EP1794585A1 Method of manufacturing an auto-calibrating sensor |
| 06/13/2007 | EP1793868A2 Contrast agents encapsulating systems for cest imaging |
| 06/13/2007 | EP1793867A2 Imaging reporters of transgene expression |
| 06/13/2007 | EP1793866A1 Luminescent metal complexes for monitoring renal function |
| 06/13/2007 | EP1759634A9 Use of 1,1,1,2-Tetrafluoroethane for lung function evaluation |
| 06/13/2007 | EP1320383B1 Photosensitisers |
| 06/13/2007 | EP0988060B1 Acid-labile and enzymatically divisible dye compounds for diagnosis with near infrared light and for therapy |
| 06/13/2007 | EP0914431B1 Truncated soluble tumor necrosis factor type-i receptors |
| 06/13/2007 | CN1980651A Treatment of myopia |
| 06/13/2007 | CN1977977A Gastro intestinal ultrasonic developer |
| 06/13/2007 | CA2820238A1 Radiographic contrasting agents and radio-opaque polymeric materials for medical devices |
| 06/13/2007 | CA2570410A1 Radiographic contrasting agents and radio-opaque polymeric materials for medical devices |
| 06/12/2007 | US7230088 Compounds for dual photodiagnosis and therapy |
| 06/12/2007 | US7230072 Site-selective acyl transfer |
| 06/12/2007 | US7229755 Isolating a biological specimen from a human; testing the specimen for an alteration in a human MSH2 nucleotide sequence or its expression product; comparing the results obtained with the results obtained from a wild type control |
| 06/12/2007 | US7229606 Diagnostic imaging contrast agents with extended blood retention |
| 06/12/2007 | US7229605 Quantitative analysis; administering to muscles of mammals |
| 06/12/2007 | US7229604 Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging |
| 06/12/2007 | US7229413 Echogenic coatings with overcoat |
| 06/12/2007 | US7229410 Method and device for determining a characteristic value for the perfusion of modified tissue regions in organs of living beings |
| 06/12/2007 | CA2324269C Mr methods for imaging pulmonary and cardiac vasculature and evaluating blood flow using dissolved polarized 129xe |
| 06/12/2007 | CA2268324C Administrable compositions and methods for magnetic resonance imaging |
| 06/12/2007 | CA2072620C Urinary tumor associated antigen, antigenic subunits uses and methods of detection |
| 06/07/2007 | WO2007065021A2 A predictive tool for hyaluronidase treatment success |
| 06/07/2007 | WO2007064227A1 Multimeric magentic resonance contrast agents |
| 06/07/2007 | WO2007063950A1 Long-wave fluorescent substance for diagnosis or treatment of conformation disease and use thereof |
| 06/07/2007 | WO2007063824A1 Precursor compound of radioactive halogen labeled organic compound |
| 06/07/2007 | WO2007021946A3 Silylamine modified nanoparticulate carriers |
| 06/07/2007 | WO2006138366A3 Protein markers |
| 06/07/2007 | WO2006093966A3 Sem cathodoluminescent imaging using up-converting nanophosphors |
| 06/07/2007 | WO2005020918A3 Ultrasonic concentration of drug delivery capsules |
| 06/07/2007 | WO2005010677A3 Characterizing biological stimuli by response curves |
| 06/07/2007 | US20070130632 Methods for introducing heterologous cells into fish |
| 06/07/2007 | US20070128672 Complementarity determining region (CDR); cancer, rheumatoid arthritis; immunology |
| 06/07/2007 | US20070128121 Polymer hydrogels for controlled release and absorption of biocides |
| 06/07/2007 | US20070128120 Organic radiographic contrasting agents for medical devices |
| 06/07/2007 | US20070128119 Pendant fatty acid imaging agents |
| 06/07/2007 | US20070128118 Polyglutamate-amino acid conjugates and methods |
| 06/07/2007 | US20070128117 Ultrasound contrast agents and process for the preparation thereof |
| 06/07/2007 | US20070128116 Multifunctional core for molecular imaging and targeted delivery of macromolecules and drugs |
| 06/07/2007 | US20070128115 Pathological tissue detection and treatment employing targeted benzoindole optical agents |
| 06/07/2007 | US20070128114 Method for monitoring protein translation |
| 06/07/2007 | US20070128113 Methods for delivering MBD peptide-linked agent into cells under conditions of cellular stress |